Direct inhibition of arcuate proopiomelanocortin neurons: A potential mechanism for the orexigenic actions of dynorphin

Journal of Physiology

Volumn 591, Issue 7, 2013, Pages 1731-1747

  Zhang, Xiaobing ^a   van den Pol, Anthony N ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; DYNORPHIN A; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; GLUTAMIC ACID; KAPPA 1 OPIATE RECEPTOR; KAPPA 2 OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR; NEUROPEPTIDE Y; PROOPIOMELANOCORTIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; BRAIN SLICE; CELL ACTIVITY; CONTROLLED STUDY; GABAERGIC TRANSMISSION; GLUTAMATE NEUROTRANSMISSION; HYPERPOLARIZATION; MOLECULAR DYNAMICS; MOUSE; NERVE FIBER; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; OREXIGENIC ACITIVITY; PATCH CLAMP; POSTSYNAPTIC INHIBITION; POTASSIUM TRANSPORT; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; SPONTANEOUS TRANSIENT OUTWARD CURRENT; VOLTAGE CLAMP;

ANIMALS; ARCUATE NUCLEUS; DYNORPHINS; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; GLUTAMIC ACID; INHIBITORY POSTSYNAPTIC POTENTIALS; MICE; MICE, TRANSGENIC; NEURONS; NEUROPEPTIDE Y; NEUROTRANSMITTER AGENTS; PRO-OPIOMELANOCORTIN; RECEPTORS, OPIOID, KAPPA; SYNAPTIC TRANSMISSION;

EID: 84875656935     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2012.248385     Document Type: Article

References (67)

1. Berman Y, Devi L & Carr KD (1994). Effects of chronic food restriction on prodynorphin-derived peptides in rat brain regions. Brain Res 664, 49-53.
2. Berman Y, Devi L, Spangler R, Kreek MJ & Carr KD (1997). Chronic food restriction and streptozotocin-induced diabetes differentially alter prodynorphin mRNA levels in rat brain regions. Brain Res Mol Brain Res 46, 25-30.
3. Blake AD, Bot G, Li S, Freeman JC & Reisine T (1997). Differential agonist regulation of the human kappa-opioid receptor. J Neurochem 68, 1846-1852.
4. Butelman ER, Ko MC, Traynor JR, Vivian JA, Kreek MJ & Woods JH (2001). GR89, 696: a potent kappa-opioid agonist with subtype selectivity in rhesus monkeys. J Pharmacol Exp Ther 298, 1049-1059.
5. Butler AA, Kesterson RA, Khong K, Cullen MJ, Pelleymounter MA, Dekoning J, Baetscher M & Cone RD (2000). A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141, 3518-3521.
6. Castillo PE, Salin PA, Weisskopf MG & Nicoll RA (1996). Characterizing the site and mode of action of dynorphin at hippocampal mossy fiber synapses in the guinea pig. J Neurosci 16, 5942-5950.
7. Caudle RM, Chavkin C & Dubner R (1994). Kappa 2 opioid receptors inhibit NMDA receptor-mediated synaptic currents in guinea pig CA3 pyramidal cells. J Neurosci 14, 5580-5589.
8. Challis BG, Coll AP, Yeo GS, Pinnock SB, Dickson SL, Thresher RR, Dixon J, Zahn D, Rochford JJ, White A, Oliver RL, Millington G, Aparicio SA, Colledge WH, Russ AP, Carlton MB & O'Rahilly S (2004). Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36). Proc Natl Acad Sci U S A 101, 4695-4700.
9. Chavkin C, James IF & Goldstein A (1982). Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 215, 413-415.
10. Chen AS, Marsh DJ, Trumbauer ME, Frazier EG, Guan XM, Yu H, Rosenblum CI, Vongs A, Feng Y, Cao L, Metzger JM, Strack AM, Camacho RE, Mellin TN, Nunes CN, Min W, Fisher J, Gopal-Truter S, MacIntyre DE, Chen HY & Van der Ploeg LH (2000a). Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 26, 97-102.
11. Chen AS, Metzger JM, Trumbauer ME, Guan XM, Yu H, Frazier EG, Marsh DJ, Forrest MJ, Gopal-Truter S, Fisher J, Camacho RE, Strack AM, Mellin TN, MacIntyre DE, Chen HY & Van der Ploeg LH (2000b). Role of the melanocortin-4 receptor in metabolic rate and food intake in mice. Transgenic Res 9, 145-154.
12. Chou TC, Lee CE, Lu J, Elmquist JK, Hara J, Willie JT, Beuckmann CT, Chemelli RM, Sakurai T, Yanagisawa M, Saper CB & Scammell TE (2001). Orexin (hypocretin) neurons contain dynorphin. J Neurosci 21, RC168.
13. Collden G, Mangano C & Meister B (2010). P2X2 purinoreceptor protein in hypothalamic neurons associated with the regulation of food intake. Neuroscience 171, 62-78.
14. Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL, Cone RD & Low MJ (2001). Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411, 480-484.
15. Czyzyk TA, Nogueiras R, Lockwood JF, McKinzie JH, Coskun T, Pintar JE, Hammond C, Tschop MH & Statnick MA (2010). kappa-Opioid receptors control the metabolic response to a high-energy diet in mice. FASEB J 24, 1151-1159.
16. DePaoli AM, Hurley KM, Yasada K, Reisine T & Bell G (1994). Distribution of kappa opioid receptor mRNA in adult mouse brain: an in situ hybridization histochemistry study. Mol Cell Neurosci 5, 327-335.
17. Dicken MS, Tooker RE & Hentges ST (2012). Regulation of GABA and Glutamate Release from Proopiomelanocortin Neuron Terminals in Intact Hypothalamic Networks. J Neurosci 32, 4042-4048.
18. Elias CF, Aschkenasi C, Lee C, Kelly J, Ahima RS, Bjorbaek C, Flier JS, Saper CB & Elmquist JK (1999). Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron 23, 775-786.
19. Elias CF, Kelly JF, Lee CE, Ahima RS, Drucker DJ, Saper CB & Elmquist JK (2000). Chemical characterization of leptin-activated neurons in the rat brain. J Comp Neurol 423, 261-281.
20. Elias CF, Lee C, Kelly J, Aschkenasi C, Ahima RS, Couceyro PR, Kuhar MJ, Saper CB & Elmquist JK (1998). Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron 21, 1375-1385.
21. Elmquist JK (2001). Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin. Physiol Behav 74, 703-708.
22. Farhang B, Pietruszewski L, Lutfy K & Wagner EJ (2010). The role of the NOP receptor in regulating food intake, meal pattern, and the excitability of proopiomelanocortin neurons. Neuropharmacology 59, 190-200.
23. Foradori CD, Amstalden M, Goodman RL & Lehman MN (2006). Colocalisation of dynorphin a and neurokinin B immunoreactivity in the arcuate nucleus and median eminence of the sheep. J Neuroendocrinol 18, 534-541.
24. Foradori CD, Coolen LM, Fitzgerald ME, Skinner DC, Goodman RL & Lehman MN (2002). Colocalization of progesterone receptors in parvicellular dynorphin neurons of the ovine preoptic area and hypothalamus. Endocrinology 143, 4366-4374.
25. Gintzler AR, Schnell SA, Gupta DS, Liu NJ & Wessendorf MW (2008). Relationship of spinal dynorphin neurons to delta-opioid receptors and estrogen receptor alpha: anatomical basis for ovarian sex steroid opioid antinociception. J Pharmacol Exp Ther 326, 725-731.
26. Glass MJ, Billington CJ & Levine AS (2000). Opioids, food reward, and macronutrient selection. In Neural and Metabolic Control of Macronutrient Intake, ed. Berthoud HR & Seeley RJ, pp. 407-423. CRC Press, New York
27. Heisler LK, Cowley MA, Kishi T, Tecott LH, Fan W, Low MJ, Smart JL, Rubinstein M, Tatro JB, Zigman JM, Cone RD & Elmquist JK (2003). Central serotonin and melanocortin pathways regulating energy homeostasis. Ann N Y Acad Sci 994, 169-174.
28. Hentges ST, Otero-Corchon V, Pennock RL, King CM & Low MJ (2009). Proopiomelanocortin expression in both GABA and glutamate neurons. J Neurosci 29, 13684-13690.
29. Herve C & Fellmann D (1997). Changes in rat melanin-concentrating hormone and dynorphin messenger ribonucleic acids induced by food deprivation. Neuropeptides 31, 237-242.
30. Horvath TL, Diano S & van den Pol AN (1999). Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations. J Neurosci 19, 1072-1087.
31. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P & Lee F (1997). Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88, 131-141.
32. Ibrahim N, Bosch MA, Smart JL, Qiu J, Rubinstein M, Ronnekleiv OK, Low MJ & Kelly MJ (2003). Hypothalamic proopiomelanocortin neurons are glucose responsive and express K(ATP) channels. Endocrinology 144, 1331-1340.
33. Inui A, Okita M, Nakajima M, Inoue T, Sakatani N, Oya M, Morioka H, Okimura Y, Chihara K & Baba S (1991). Neuropeptide regulation of feeding in dogs. Am J Physiol Regul Integr Comp Physiol 261, R588-594.
34. Jordan BA & Devi LA (1999). G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399, 697-700.
35. Khawaja XZ, Chattopadhyay AK & Green IC (1991). Increased beta-endorphin and dynorphin concentrations in discrete hypothalamic regions of genetically obese (ob/ob) mice. Brain Res 555, 164-168.
36. Kittner H, Franke H, Harsch JI, El-Ashmawy IM, Seidel B, Krugel U & Illes P (2006). Enhanced food intake after stimulation of hypothalamic P2Y1 receptors in rats: modulation of feeding behaviour by extracellular nucleotides. Eur J Neurosci 24, 2049-2056.
37. Li Y & van den Pol AN (2006). Differential target-dependent actions of coexpressed inhibitory dynorphin and excitatory hypocretin/orexin neuropeptides. J Neurosci 26, 13037-13047.
38. Maolood N & Meister B (2008). Dynorphin in pro-opiomelanocortin neurons of the hypothalamic arcuate nucleus. Neuroscience 154, 1121-1131.
39. Maolood N & Meister B (2010). Nociceptin/orphanin FQ peptide in hypothalamic neurones associated with the control of feeding behaviour. J Neuroendocrinol 22, 75-82.
40. Marsh DJ, Weingarth DT, Novi DE, Chen HY, Trumbauer ME, Chen AS, Guan XM, Jiang MM, Feng Y, Camacho RE, Shen Z, Frazier EG, Yu H, Metzger JM, Kuca SJ, Shearman LP, Gopal-Truter S, MacNeil DJ, Strack AM, MacIntyre DE, Van der Ploeg LH & Qian S (2002). Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. Proc Natl Acad Sci U S A 99, 3240-3245.
41. Morley JE & Levine AS (1983). Involvement of dynorphin and the kappa opioid receptor in feeding. Peptides 4, 797-800.
42. Morley JE, Levine AS, Grace M & Kneip J (1982). Dynorphin-(1-13), dopamine and feeding in rats. Pharmacol Biochem Behav 16, 701-705.
43. Navarro VM, Gottsch ML, Chavkin C, Okamura H, Clifton DK & Steiner RA (2009). Regulation of gonadotropin-releasing hormone secretion by kisspeptin/dynorphin/neurokinin B neurons in the arcuate nucleus of the mouse. J Neurosci 29, 11859-11866.
44. Naylor A, Judd DB, Lloyd JE, Scopes DI, Hayes AG & Birch PJ (1993). A potent new class of kappa-receptor agonist: 4-substituted 1-(arylacetyl)-2 -[(dialkylamino)methyl]piperazines. J Med Chem 36, 2075-2083.
45. Nock B, Giordano AL, Cicero TJ & O'Connor LH (1990). Affinity of drugs and peptides for U-69, 593-sensitive and -insensitive kappa opiate binding sites: the U-69, 593-insensitive site appears to be the beta endorphin-specific epsilon receptor. J Pharmacol Exp Ther 254, 412-419.
46. Nock B, Giordano AL, Moore BW & Cicero TJ (1993). Properties of the putative epsilon opioid receptor: identification in rat, guinea pig, cow, pig and chicken brain. J Pharmacol Exp Ther 264, 349-359.
47. Nock B, Rajpara A, O'Connor LH & Cicero TJ (1988). Autoradiography of [3H]U-69593 binding sites in rat brain: evidence for kappa opioid receptor subtypes. Eur J Pharmacol 154, 27-34.
48. Ogura M & Kita H (2000). Dynorphin exerts both postsynaptic and presynaptic effects in the Globus pallidus of the rat. J Neurophysiol 83, 3366-3376.
49. Pelton JT, Kazmierski W, Gulya K, Yamamura HI & Hruby VJ (1986). Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for mu opioid receptors. J Med Chem 29, 2370-2375.
50. Pennock RL & Hentges ST (2011). Differential expression and sensitivity of presynaptic and postsynaptic opioid receptors regulating hypothalamic proopiomelanocortin neurons. J Neurosci 31, 281-288.
51. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG & Kilduff TS (1998). Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18, 9996-10015.
52. Portoghese PS, Lin CE, Farouz-Grant F & Takemori AE (1994). Structure-activity relationship of N17'-substituted norbinaltorphimine congeners. Role of the N17' basic group in the interaction with a putative address subsite on the kappa opioid receptor. J Med Chem 37, 1495-1500.
53. Qu D, Ludwig DS, Gammeltoft S, Piper M, Pelleymounter MA, Cullen MJ, Mathes WF, Przypek R, Kanarek R & Maratos-Flier E (1996). A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 380, 243-247.
54. Roane DS, Iadarola MJ & Porter JR (1988). Decreased [3H]-naloxone binding and elevated dynorphin-A(1-8) content in Zucker rat brain. Physiol Behav 43, 371-374.
55. Rothman RB, Bykov V, Xue BG, Xu H, De Costa BR, Jacobson AE, Rice KC, Kleinman JE & Brady LS (1992). Interaction of opioid peptides and other drugs with multiple kappa receptors in rat and human brain. Evidence for species differences. Peptides 13, 977-987.
56. Sainsbury A, Lin S, McNamara K, Slack K, Enriquez R, Lee NJ, Boey D, Smythe GA, Schwarzer C, Baldock P, Karl T, Lin EJ, Couzens M & Herzog H (2007). Dynorphin knockout reduces fat mass and increases weight loss during fasting in mice. Mol Endocrinol 21, 1722-1735.
57. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ & Yanagisawa M (1998). Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92, 573-585.
58. Schwartz MW, Woods SC, Porte D, Jr, Seeley RJ & Baskin DG (2000). Central nervous system control of food intake. Nature 404, 661-671.
59. Shimada M, Tritos NA, Lowell BB, Flier JS & Maratos-Flier E (1998). Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 396, 670-674.
60. Shuster SJ, Riedl M, Li X, Vulchanova L & Elde R (2000). The kappa opioid receptor and dynorphin co-localize in vasopressin magnocellular neurosecretory neurons in guinea-pig hypothalamus. Neuroscience 96, 373-383.
61. Silva RM, Grossman HC, Hadjimarkou MM, Rossi GC, Pasternak GW & Bodnar RJ (2002). Dynorphin A(1-17)-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats. J Pharmacol Exp Ther 301, 513-518.
62. Slugg RM, Hayward MD, Ronnekleiv OK, Low MJ & Kelly MJ (2000). Effect of the mu-opioid agonist DAMGO on medial basal hypothalamic neurons in beta-endorphin knockout mice. Neuroendocrinology 72, 208-217.
63. Tsukamoto G, Ichikawa H, Kobashi M, Yamada Y, Kikuchi T, Mese H & Sasaki A (2007). Cisplatin-induced long-term dynorphin A-immunoreactivity in cell somata of rat area postrema neurons. Neurosci Lett 424, 122-126.
64. van den Pol AN, Gao XB, Obrietan K, Kilduff TS & Belousov AB (1998). Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J Neurosci 18, 7962-7971.
65. van den Pol AN, Yao Y, Fu LY, Foo K, Huang H, Coppari R, Lowell BB & Broberger C (2009). Neuromedin B and gastrin-releasing peptide excite arcuate nucleus neuropeptide Y neurons in a novel transgenic mouse expressing strong Renilla green fluorescent protein in NPY neurons. J Neurosci 29, 4622-4639.
66. Yamada K, Park H, Sato S, Onozuka M, Kubo K & Yamamoto T (2008). Dynorphin-A immunoreactive terminals on the neuronal somata of rat mesencephalic trigeminal nucleus. Neurosci Lett 438, 150-154.
67. Zukin RS, Eghbali M, Olive D, Unterwald EM & Tempel A (1988). Characterization and visualization of rat and guinea pig brain kappa opioid receptors: evidence for kappa 1 and kappa 2 opioid receptors. Proc Natl Acad Sci U S A 85, 4061-4065.